AI-driven adaptive cardiac devices to improve heart disease treatment

These solutions highlight the industry’s shift to precision medicine.

AI-driven adaptive cardiac devices are set to improve patient outcomes by enabling real-time monitoring and dynamic therapy adjustments, said GlobalData.

The report said these devices ensure a personalised approach that aligns with a patient’s changing condition, offering round-the-clock intervention.

“AI-enhanced solutions exemplify the industry’s shift toward precision medicine, aligning with regulatory bodies like the FDA,” said Cynthia Stinchcombe, Medical Devices Analyst at GlobalData.

Stinchcombe added that the cardiovascular devices market is experiencing rapid expansion and diversification.

The sector is projected to reach $140b by 2033 at a compound annual growth rate of 5.20%.